
Dan Chen
@DanChenMDPhD
Followers
3K
Following
3K
Media
36
Statuses
1K
Co-author of the cancer-immunity cycle and the immune set point with Ira Mellman; Opinions are my own.
Joined August 2014
RT @JohnCendpts: We all know it's tough out there in @biotech land. Down rounds, IPO window shut, Trumpster fires, all of that. But the sta….
0
8
0
RT @BertrandBio: discussant slides on $SMMT #Akeso ivonescimab / $BNTX #Biotheus BNT327 - PM8002 in TNBC, ESG401 TROP2 ADC in HR+/HER2- & T….
0
1
0
RT @JonathanWosen: Genentech, a biotech with a storied past, confronts new turbulence in the present. My story for @statnews, based on inte….
statnews.com
Genentech is a biotech company with a storied past. But what will happen in its future?
0
3
0
Amazing to have Jesse B. Owens, Jennifer Manning, Omid Harandi, Jay Wohlgemuth, Ray Tabibiazar, +++ as partners and founders making this happen!
linkedin.com
KOMO Biosciences | 1,274 followers on LinkedIn. Next-Generation Targeted Gene Integration Technology | KOMO Biosciences is a next-generation targeted gene integration technology company driven by the...
0
0
2
KOMO BIOSCIENCES- #gene #modification, from the dish, accelerating biologic therapy development and manufacturing, to patients. It's exactly the broad #technology and #engineering that Genesis seeks to create, incubate and help grow into companies that benefit human health.
2
0
1
Super excited and happy to launch KOMO BIOSCIENCES, the first Genesis BioCapital company and technology! Komo is set to deliver transformative advances in #gene modification.
endpoints.news
Scientists at the University of Hawaii have improved tools for making large changes to genomes and have licensed the technology to a new startup called Komo Biosciences, its leaders told ...
1
0
5
RT @tompowles1: Neoadjuvant chemo/nivo with adjuvant nivo show ⬆️ DFS (HR 0.58) & ⬆️pCR in NSCLC. 23% & 35% didn’t have surgery/adjuvant n….
0
30
0
Advances here will not only lead to more powerful therapeutics, it will usher in Directed Design and help us keep our human understanding up with #ai driven findings. Immunity as biophysics at the surface of a T cell.
1
1
1
One of the important gaps in our understanding of biology comes from thinking of interactions as 2D diagrams rather than a series of biophysical interactions that occur, for instance, at the cell surface. # cancer #immunity #Immunotherapy #biophysics.
1
3
5
Such an important discovery published by the @KoleRoybal and @jaehyukchoimd labs relating to specific mutations that can drive non-physiologic T cell functional states. Implications for both our understanding of T cell biology and #cancer #immunotherapy approaches.
2
7
18
Continued support for the importance of PDL1 pathway inhibition combined with VEGF blockade. An interesting Venn diagram for non-overlapping but related biology between #cancer #immunotherapy and #angiogenesis. Positive trials now in #NSCLC #HCC #RCC #ProstateCancer #endometrial.
💫🌟Fantastic talk with the usual clarity!!!👏👏👏.🔬 🔝🔝🔝#CONTACT-2 Phase 3 Study Results are in! Combining cabozantinib & atezolizumab shows promise for mCRPC. By @neerajaiims .🎯 Highlights:.mCRPC with prior NHT failure, extrapelvic nodal or visceral metastasis. 📊 Key
0
0
4
RT @ImmunityCP: As we get ready for 2024, let's look back at the Immunity covers of 2023! Thank you to everyone that contributed to the sci….
0
16
0
RT @bradloncar: Think this is the most interesting office I’ve visited in Silicon Valley. Love the board in the background with the names o….
0
2
0